Cost-effectiveness analysis of telaprevir triple therapy for treatment-naive patients with chronic hepatitis C based on the combined efficacy data of the ADVANCE and OPTIMIZE studies
Date issued
2013Journal title
Hepatology
Type of content
Publicación de congreso